Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 2, 2013, Pages 287-292

  Mognetti, Barbara ^a   Montagna, Giuseppe La ^a   Perrelli, Maria Giulia ^a   Pagliaro, Pasquale ^a   Penna, Claudia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bone metastases; Co culture; Mesenchymal stem cells; Prostate cancer

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HETEROCYCLIC COMPOUND; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLERIXAFOR; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1;

ANIMAL; ARTICLE; BONE MARROW; CELL MOTION; CELL PROLIFERATION; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PROSTATE TUMOR; RAT; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; ANTI-HIV AGENTS; BLOTTING, WESTERN; BONE MARROW; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; CULTURE MEDIA, CONDITIONED; HETEROCYCLIC COMPOUNDS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; TUMOR CELLS, CULTURED;

EID: 84874396633     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12010     Document Type: Article

References (40)

1. Cooper CR, Chay CH, Gendernalik JD, et al. Stromal factors involved in prostate carcinoma metastasis to bone. Cancer Res 2003; 97: 739-47.
2. Delorme B, Charbord P. Culture and characterization of human bone marrow mesenchymal stem cells. Methods Mol Med 2007; 140: 67-81.
3. Dmitrieva RI, Minullina IR, Bilibina AA, et al. Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle 2012; 11: 377-83.
4. Zhang M, Mal N, Kiedrowski M, et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007; 21: 3197-207.
5. Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005; 201: 1307-18.
6. Domanska UM, Kruizinga RC, Nagengast WB, et al. A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur J Cancer 2013; 49: 219-30.
7. Burger JA. KippsTJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107: 1761-7.
8. Hall JM, Korach KS. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 2003; 17: 792-803.
9. Taichman RS, Cooper C, Keller ET, et al. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002; 62: 1832-7.
10. Kaifi JT, Yekebas EF, Schurr P, et al. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Nat Cancer Inst 2005; 97: 1840-7.
11. Kim SY, Lee CH, Midura BV, et al. Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 2008; 25: 201-11.
12. Geminder H, Sagi-Assif O, Goldberg L, et al. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001; 167: 4747-57.
13. Jin F, Brockmeier U, Otterbach F, et al. New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation. Mol Cancer Res 2012; 10: 1021-31.
14. Dewan MZ, Ahmed S, Iwasaki Y, et al. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother 2006; 60: 273-6.
15. Campbell JP, Karolak MR, Ma Y, et al. Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol 2012; 10: e1001363.
16. Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene 2008; 27: 5904-12.
17. Shinagawa K, Kitadai Y, Tanaka M, et al. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. Int J Cancer 2013; 132: 813-23.
18. Annabi B, Naud E, Lee YT, et al. Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. J Cell Biochem 2004; 91: 1146-58.
19. Sun B, Zhang S, Ni C, et al. Correlation between melanoma angiogenesis and the mesenchymal stem cells and endothelial progenitor cells derived from bone marrow. Stem Cells Dev 2005; 14: 292-8.
20. Zhu W, Xu W, Jiang R, et al. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 2006; 80: 267-74.
21. Liu S, Ginestier C, Ou SJ, et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 2011; 71: 614-24.
22. Shinagawa K, Kitadai Y, Tanaka M, et al. Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer 2010; 127: 2323-33.
23. Gallo MP, Ramella R, Alloatti G, et al. Limited plasticity of mesenchymal stem cells cocultured with adult cardiomyocytes. J Cell Biochem 2007; 100: 86-99.
24. Muscari C, Bonafé F, Stanic I, et al. Polyamine depletion reduces TNFalpha/MG132-induced apoptosis in bone marrow stromal cells. Stem Cells 2005; 23: 983-91.
25. Raimondo S, Penna C, Pagliaro P, et al. Morphological characterization of GFP stably transfected adult mesenchymal bone marrow stem cells. J Anat 2006; 208: 3-12.
26. Penna C, Alloatti G, Cappello S, et al. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. Am J Physiol Heart Circ Physiol 2005; 288: H2512-20.
27. Gambarotta G, Garzotto D, Destro E, et al. ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1 beta 1-induced migration. J Biol Chem 2004; 279: 48808-16.
28. Wang L, Li C-L, Wang L, et al. Influence of CXCR4/SDF-1 axis on E-cadherin/β-catenin complex expression in HT29 colon cancer cells. World J Gastroenterol 2011; 15: 625-32.
29. Li J-K, Yu L, Yun S, et al. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J Gastroenterol 2008; 14: 2308-13.
30. Schiller KR, Zillhardt MR, Alley J, et al. Secretion of MCP-1 and other paracrine factors in a novel tumor-bone cocuture model. BMC Cancer 2009; 9: 45-62.
31. Shiozawa Y, Pedersen EA, Havens AM, et al. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest 2011; 121: 1298-312.
32. Mochizuki H, Matsubara A, Teishima J, et al. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis. Biochem Bioph Res Commun 2004; 320: 656-63.
33. Ibrahim T, Sacanna E, Gaudio M, et al. Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. Clin Breast Cancer 2011; 11: 369-75.
34. Ok S, Kim SM, Kim C, et al. Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4. Immunopharmacol Immunotoxicol 2012; 34: 768-78.
35. Chinni SR, Sivalogan S, Dong Z, et al. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate 2006; 66: 32-48.
36. Wojcechowskyj JA, Lee JY, Seeholzer SH, et al. Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling. PLoS ONE 2012; 6: e24918.
37. Freeman MR, Bastias MC, Hill GA, et al. Coculture of mouse embryos with cells isolated from the human ovarian follicle, oviduct, and uterine endometrium. Fertil Steril 1993; 59: 138-42.
38. Sweeny L, Zimmermann TM, Liu Z, et al. Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts. Oral Oncol 2012; 48: 1242-9.
39. Tsuyada A, Chow A, Wu J, et al. CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res 2012; 72: 2768-79.
40. Crump MP, Gong JH, Loetscher P, et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 1997; 16: 6996-7007.